GOLD PR expands its health & beauty practice with the addition of Zeltiq

Los Angeles, Calif. – Feb. 23, 2010 – GOLD PR, an independent boutique PR firm, today announced the addition of ZELTIQ™ to its growing roster of health & beauty clients. ZELTIQ is an early stage medical device company that developed CoolSculpting™, the first and only non-invasive, clinically proven procedure to selectively reduce fat layers in problem areas using a patented cooling technology which is currently awaiting FDA Clearance from the U.S. Food and Drug Administration (FDA).

“ZELTIQ is a pioneer in the non-invasive fat reduction and body contouring market and we are honored to have been selected as their consumer PR agency of record to support the global launch of the brand and its breakthrough CoolSculpting procedure,” said Shari Gold, principal at GOLD PR.

CoolSculpting™ is a new way to gently reduce fat in targeted areas of the body that results in a noticeable, natural-looking cosmetic improvement of the treated fat bulges. Unlike most other methods of fat reduction, ZELTIQ’s CoolSculpting procedure involves no needles, surgery or downtime.

About ZELTIQ
Founded in 2005, ZELTIQ is an early stage medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat. The initial Cryolipolysis research and patents were originated at the Wellman Center by Dr. Dieter Manstein and Dr. R. Rox Anderson. ZELTIQ has exclusive rights to this innovative “cool” approach to permanently removing fat. CoolScultping is already cleared by Health Canada and the European Union for non-invasive fat layer reduction. Physicians and consumers are encouraged to visit www.coolsculpting.com to receive additional information and announcements about CoolScultping by ZELTIQ.